Effective Treatment of Staphylococcus aureus Intramammary Infection in a Murine Model Using the Bacteriophage Cocktail StaphLyse™
Viruses · 2023
DOI: 10.3390/v15040887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Eric Brouillette und 9 weiteren Autor:innen. Beteiligte Einrichtung: Département de Biologie, Faculté des Sciences, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada. Hauptthemen laut MEDLINE: Bacteriophages, Mastitis, Bovine, Staphylococcal Infections. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Université de Sherbrooke, Fonds de Recherche du Québec-Nature et Technologie (FRQ-NT).
Abstract (Originalsprache)
Staphylococcus aureus causes intramammary infections (IMIs), which are refractory to antibiotic treatment and frequently result in chronic mastitis. IMIs are the leading cause of conventional antibiotic use in dairy farms. Phage therapy represents an alternative to antibiotics to help better manage mastitis in cows, reducing the global spread of resistance. A mouse mastitis model of S. aureus IMI was used to study the efficacy of a new cocktail of five lytic S. aureus-specific phages (StaphLyse™), administered either via the intramammary (IMAM) route or intravenously (IV). The StaphLyse™ phage cocktail was stable in milk for up to one day at 37 °C and up to one week at 4 °C. The phage cocktail was bactericidal in vitro against S. aureus in a dose-dependent manner. A single IMAM injection of this cocktail given 8 h after infection reduced the bacterial load in the mammary glands of lactating mice infected with S. aureus, and as expected, a two-dose regimen was more effective. Prophylactic use (4 h pre-challenge) of the phage cocktail was also effective, reducing S. aureus levels by 4 log10 CFU per gram of mammary gland. These results suggest that phage therapy may be a viable alternative to traditional antibiotics for the control of S. aureus IMIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Département de Biologie, Faculté des Sciences, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.
- Techniques de Santé Animale, Cégep de Sherbrooke, Sherbrooke, QC J1E 4K1, Canada.
- Sherbrooke Research and Development Centre, Agriculture and Agri-Food Canada, Sherbrooke, QC J1M 0C8, Canada.
- Phileo by Lesaffre North America Office, 7475 West Main Street, Milwaukee, WI 53214, USA.
- Intralytix, Inc., Columbia, MD 21046, USA.
ORCID-Profile: Guillaume Millette, Céline Ster
Förderung
- Université de Sherbrooke
- Fonds de Recherche du Québec-Nature et Technologie (FRQ-NT)
Zitieren
APA
Brouillette, E., Millette, G., Chamberland, S., Roy, J. P., Ster, C., Kiros, T., Hickey, S., Hittle, L., Woolston, J., & Malouin, F. (2023). Effective Treatment of Staphylococcus aureus Intramammary Infection in a Murine Model Using the Bacteriophage Cocktail StaphLyse™. Viruses. https://doi.org/10.3390/v15040887
Vancouver
Brouillette E, Millette G, Chamberland S, Roy JP, Ster C, Kiros T, et al. Effective Treatment of Staphylococcus aureus Intramammary Infection in a Murine Model Using the Bacteriophage Cocktail StaphLyse™. Viruses. 2023. doi:10.3390/v15040887
BibTeX
@article{Brouillette2023,
author = {Brouillette, Eric and Millette, Guillaume and Chamberland, Suzanne and Roy, Jean-Pierre and Ster, Céline and Kiros, Tadele and Hickey, Stephanie and Hittle, Lauren and Woolston, Joelle and Malouin, François},
title = {Effective Treatment of Staphylococcus aureus Intramammary Infection in a Murine Model Using the Bacteriophage Cocktail StaphLyse™},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040887}
}
EUVIMED